Literature DB >> 7544516

Worldwide patterns of prevalence and mortality from benign prostatic hyperplasia.

P Napalkov1, P Maisonneuve, P Boyle.   

Abstract

Benign prostatic hyperplasia (BPH) can be found in 88% of autopsies in men > or = 80 years, with compatible symptomatology reported in nearly 50% of men aged > or = 50 years in the general population. Despite such a common occurrence, little is known with any certainty about the epidemiology of BPH (for which "prostatism" is a commonly, and wrongly, used synonym). Knowledge of risk factors is sparse: analytic epidemiologic studies of BPH are difficult to conduct. It is essential to establish an epidemiologic definition of BPH for these reasons. Both BPH and prostatism are the problems that seem set to increase in absolute terms. They are clearly identified as priority areas for research into their causes and treatment. However, it is clear that there is a great need for more epidemiologic information, particularly regarding prostatism, whose occurrence is unknown in many parts of the world.

Entities:  

Mesh:

Year:  1995        PMID: 7544516     DOI: 10.1016/s0090-4295(99)80249-0

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  11 in total

1.  The effects of Pueraria mirifica extract, diadzein and genistein in testosterone-induced prostate hyperplasia in male Sprague Dawley rats.

Authors:  Jamaludin Mohamad; Siti Saleha Masrudin; Zazali Alias; Nur Airina Muhamad
Journal:  Mol Biol Rep       Date:  2019-02-01       Impact factor: 2.316

2.  Dutasteride: a review of current data on a novel dual inhibitor of 5alpha reductase.

Authors:  Sibylle Marihart; Mike Harik; Bob Djavan
Journal:  Rev Urol       Date:  2005

3.  5α-reductase type 3 expression in human benign and malignant tissues: a comparative analysis during prostate cancer progression.

Authors:  Alejandro Godoy; Elzbieta Kawinski; Yun Li; Daizo Oka; Borislav Alexiev; Faris Azzouni; Mark A Titus; James L Mohler
Journal:  Prostate       Date:  2010-12-28       Impact factor: 4.104

4.  The effects of transurethral resection of the prostate on morbidity and mortality in patients with nondialysis-requiring renal insufficiency.

Authors:  Alp Ozgur Akdemir; Cetin Volkan Oztekin; Omer Gokhan Doluoglu; Mehmet Karabakan; Ozgur Ugurlu; Mesut Cetinkaya
Journal:  Ther Adv Urol       Date:  2012-04

5.  Demographic and comorbidity profile of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a real-life clinical setting: Are 5-alpha-reductase inhibitor consumers different?

Authors:  Ferdinando Fusco; Davide Arcaniolo; Massimiliano Creta; Gaetano Piccinocchi; Giovanni Arpino; Matteo Laringe; Roberto Piccinocchi; Nicola Longo; Paolo Verze; Francesco Mangiapia; Vittorio Imperatore; Vincenzo Mirone
Journal:  World J Urol       Date:  2014-12-10       Impact factor: 4.226

6.  Efficacy of low-dose tamsulosin on lower urinary tract symptoms suggestive of benign prostatic hyperplasia : a nonblind multicentre korean study.

Authors:  Choal Hee Park; Hyuk Soo Chang; Bong Ryul Oh; Hyung Jee Kim; Chong Koo Sul; Sung Kwang Chung; Se Il Jung
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

7.  A prostate-specific antigen-activated channel-forming toxin as therapy for prostatic disease.

Authors:  Simon A Williams; Rosemina F Merchant; Elizabeth Garrett-Mayer; John T Isaacs; J Thomas Buckley; Samuel R Denmeade
Journal:  J Natl Cancer Inst       Date:  2007-03-07       Impact factor: 13.506

8.  The psychometric validation of a US English satisfaction measure for patients with benign prostatic hyperplasia and lower urinary tract symptoms.

Authors:  Libby Black; Alyson Grove; Betsy Morrill
Journal:  Health Qual Life Outcomes       Date:  2009-06-19       Impact factor: 3.186

9.  Herbal medicine for benign prostatic hyperplasia: A protocol for a systematic review of controlled trials.

Authors:  Ji Hwan Kim; Kyung Moo Park; Ju Ah Lee
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

10.  Study of correlation of urodynamic profile with symptom scoring and ultrasonographic parameters in patients with benign prostatic hyperplasia.

Authors:  Ankur Garg; Shweta Bansal; Sudipta Saha; Ajay Kumar
Journal:  J Family Med Prim Care       Date:  2020-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.